Your new experience awaits. Try the new design now and help us make it even better

PERSPECTIVE article

Front. Hematol.

Sec. Hematopoiesis and Stem Cells

A megakaryocyte in the peripheral blood: evidence for pulmonary migration?

Provisionally accepted
  • 1Department of Haematology and Cell Biology, School of Pathology, University of the Free State, Bloemfontein, South Africa
  • 2Universitas Academic Laboratory, National Health Laboratory Service, Johannesburg, South Africa

The final, formatted version of the article will be published soon.

Pulmonary megakaryocytes were first identified over a century ago, but their origin is still debated. Two rare images of circulating megakaryocytes are presented to illustrate this discussion: The first shows an intact megakaryocyte with abundant cytoplasm and a hyperlobulated nucleus on a peripheral smear made from blood drawn through a Hickman line in a child with B-cell acute lymphoblastic leukaemia. The morphology of this megakaryocyte is contrasted with that of the second image, from a patient with primary myelofibrosis. This perspective focuses on the first image, which illustrates several hypotheses regarding the origin and function of pulmonary megakaryocytes. According to the most widely accepted theory, this megakaryocyte may have originated in the bone marrow (BM), entered the venous circulation, and migrated to the lungs, where it was aspirated from the superior vena cava before being trapped in the pulmonary vasculature to exert its incompletely understood functions. In this child with acute leukaemia, it could have been a role-player the cancer immune response. Alternatively, pulmonary megakaryocytes may have been compensating for the displacement of platelet-producing megakaryocytes by blasts in the BM. While a single anecdotal image cannot provide mechanistic evidence, this megakaryocyte, when interpreted in its clinical context, provides visual support for (1) the hypotheses that at least some pulmonary megakaryocytes have a BM origin, (2) the theory that lung megakaryocytes may augment platelet production during thrombocytopenic states, and (3) chemotherapy-induced megakaryocyte release from the BM. It serves as a reminder that we should continue to draw insights from clinical observations.

Keywords: Circulating megakaryocyte, Peripheral blood megakaryocyte, Pulmonarymegakaryocytes, Lung megakaryocytes, Thrombopoiesis

Received: 05 Aug 2025; Accepted: 30 Oct 2025.

Copyright: © 2025 Kennedy. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Stephanie Juané Kennedy, kennedysj@ufs.ac.za

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.